AstraZeneca and University of Oxford's vaccine showed 90% efficacy when it was given to 2,741 people as a half-dose followed by a full dose and 62% efficacy when two full doses were given to 8,895 people.
AstraZeneca and University of Oxford's vaccine showed 90% efficiency when it was given to 2,741 people as a half-dose followed by a full dose and 62% efficiency when two full doses were given to 8,895 people. That averaged to a 70% efficiency.
AstraZeneca and University of Oxford's vaccine showed 90% efficacy when it was given to 2,741 people as a half-dose followed by a full dose and 62% efficacy when two full doses were given to 8,895 people.